Clinical performance of Rose K2 soft contact lens for keratoconus
Article Quality & Performance Metrics
Readership in this journal
EmergingRanked #19 of 48 articles by views in guoji yanke zazhi
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
Abstract
METHODS: Fifty eyes of 50 participants were included in this cross-sectional study. Each participant received a full ophthalmologic examination involving refraction, uncorrected visual acuity(UCVA), best spectacle corrected visual acuity(BCVA), slit-lamp biomicroscopy-fundoscopy, break-up time(BUT), corneal topography, and contrast sensitivity. After contact lens was fitted best contact lens corrected visual acuity(BCLCVA), contrast sensitivity, and comfort rating via visual analogue scales(VAS)were performed.
RESULTS: The mean age was 26.2±6.0(range: 16 to 39)y. The mean logMAR UCVA, BCVA, and BCLCVA with Rose K2 soft(in order)were 0.61±0.37(range: 0.15-1.3), 0.42±0.32(range: 0-1.3), and 0.18±0.20(range: 0-1.3). There were significant increases in visual acuities with contact lenses(P < 0.05). The mean contrast sensitivity scores were significantly better with both contact lens in mesopic and photopic conditions(P <0.05). The mean VAS score was 8.02±1.64(range: 5-10)for Rose K2 soft.
CONCLUSION: Rose K2 soft contact lens can improve visual acuity, contrast sensitivity with comfort in patients with keratoconus.
| Reference Key |
yilmaz2017clinicalguoji
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yilmaz, Ihsan;Ozcelik, Ferah;Demir, Gokhan;Durusoy, Gonul;Saracoglu, Basak;Taskapili, Muhittin; |
| Journal | guoji yanke zazhi |
| Year | 2017 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.